Query author contributions in Reactome Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome .
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Ligand-independent dimerization of PDGFR mutants
Class:Id Reaction:9672168
_displayName Ligand-independent dimerization of PDGFR mutants
_doRelease TRUE
_timestamp 2020-02-27 15:47:11
authored [InstanceEdit:9677035] Rothfels, Karen, 2020-02-25
compartment [Compartment:876] plasma membrane
created [InstanceEdit:9672161] Rothfels, Karen, 2019-12-23
disease [Disease:1500689] cancer
edited [InstanceEdit:9677035] Rothfels, Karen, 2020-02-25
entityFunctionalStatus [EntityFunctionalStatus:9672155] gain_of_function of PDGFR mutant receptors [plasma membrane]
input [DefinedSet:9672123] PDGFR mutant receptors [plasma membrane] [Homo sapiens] [DefinedSet:9672123] PDGFR mutant receptors [plasma membrane] [Homo sapiens]
isChimeric FALSE
literatureReference [LiteratureReference:9671898] PDGFRA activating mutations in gastrointestinal stromal tumors [LiteratureReference:9671911] PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib [LiteratureReference:9673515] Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors [LiteratureReference:9673583] The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders [LiteratureReference:9671447] Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases [LiteratureReference:9671907] PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations [LiteratureReference:9676100] GEIS guidelines for gastrointestinal sarcomas (GIST) [LiteratureReference:9671886] Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
modified [InstanceEdit:9673765] Rothfels, Karen, 2020-01-08 [InstanceEdit:9676111] Rothfels, Karen, 2020-02-07 [InstanceEdit:9676333] Rothfels, Karen, 2020-02-12 [InstanceEdit:9677115] Rothfels, Karen, 2020-02-27 [InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
name Ligand-independent dimerization of PDGFR mutants
normalReaction
output [DefinedSet:9672131] PDGFR mutant dimers [plasma membrane] [Homo sapiens]
releaseDate 2020-03-17
reviewed [InstanceEdit:9676030] Ip, Carman K M, 2020-02-06
reviewStatus [ReviewStatus:9821382] five stars
species [Species:48887] Homo sapiens
stableIdentifier [StableIdentifier:9672189] R-HSA-9672168.2
summation [Summation:9673741] Activating missense and small in-frame deletion mutations in...
(hasEvent) [Pathway:9673767] Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants [Homo sapiens]
(precedingEvent) [Reaction:9672175] Autophosphorylation of PDGFR mutant dimers [Homo sapiens]
[Change default viewing format]
List...
Protein identifiers
ChEBI identifiers
KEGG COMPOUND identifiers
No pathways have been reviewed or authored by Ligand-independent dimerization of PDGFR mutants (9672168)